NEW YORK — Gencove, the leading low-pass genome sequencing platform, announced today a $3 million investment led by Spero Ventures. Alexandria Venture Investments and Burst Capital participated in the round, along with existing investors Third Kind Venture Capital and Version One Ventures. The funding will be used to develop new applications for agricultural markets as well as expand Gencove’s […]
Oxford Nanopore has today made Flongle starter packs available to purchase, after initial testing in an early-access programme. Flongle introduces a new paradigm of smaller, on-demand DNA or RNA sequencing tests, with the potential to transform a range of applications where rapid insights are required at low cost. Oxford Nanopore’s goal is to enable the analysis […]
IDBS, a leader in enterprise scientific informatics platforms, is pleased to announce a new SaaS contract with Genevant Sciences Corporation, a leading biopharmaceutical company focused on the discovery and development of a broad range of RNA-based therapeutics across multiple modalities. The arrangement will combine Genevant’s RNA therapeutic expertise with the R&D and discovery data management expertise of IDBS. […]
Othram wins a research grant from Illumina Accelerator and presents at SXSW on breakthrough sequencing and informatics techniques for reconstructing genomes from challenging DNA samples. THE WOODLANDS, TEXAS Othram, Inc. was awarded a research sequencing grant from Illumina Accelerator after presenting at SXSW for the “Digitizing Biology Through Genomics” session as part of the Energizing […]
Product is the result of a partnership with Integrated DNA Technologies, and provides clinical-stage clients with a critical raw material FARGO, ND: Aldevron, a leading contract development and manufacturing organization serving the biotech industry, announces the release of GMP SpyFi Cas9 Nuclease for clinical and commercial applications. SpyFi Cas9 Nuclease, the trade name for Aldevron’s research grade and GMP […]
Product is the result of a partnership with Integrated DNA Technologies, Inc., and provides clinical stage clients with a critical raw material Aldevron is announcing the release of GMP SpyFi Cas9 Nuclease for clinical and commercial applications. SpyFi Cas9 Nuclease, the trade name for Aldevron’s research grade and GMP products, is the direct result of a partnership […]
Natera and BGI Genomics Announce $50M Partnership to Commercialize Signatera Oncology Test in China and to Develop Reproductive Health Tests in Select Markets on BGI’s DNBseq™ Technology Platform Partnership marks significant milestone for Natera in monetizing its Signatera MRD test and for BGI Genomics a strong endorsement of its DNBseq™ technology platform by a leader […]
The Regeneron Genetics Center successfully deployed the cohort browser against a large genomic and phenotypic UK Biobank data set MOUNTAIN VIEW, Calif.–DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the addition of an innovative browser for clinico-genomic cohorts to its DNAnexus Apollo™ Platform, allowing for easy at-scale navigation and exploration on […]
Non-exclusive collaboration aims to accelerate adoption and ease of use in processing single-tube sample collection version of the market-leading modern blood test for latent TB detection Männedorf, Switzerland, and Germantown, Maryland, Hilden, Germany – The Tecan Group (SIX Swiss Exchange: TECN) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global provider of Sample to Insight […]
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing CORALVILLE, IA – As a dedicated innovator of tools and solutions for genomics applications, Integrated DNA Technologies (IDT) introduces its unique, rhAmpSeq™ targeted sequencing system – providing researchers with highly accurate, cost-effective and easy-to-use amplicon sequencing on Illumina® next-generation sequencing (NGS) platforms. The proprietary rhAmpSeq […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
